依托孕烯皮下埋植剂使用现状调查研究

发布时间：2018-02-01 11:23

本文关键词： 依托孕烯随访调查使用效果不良反应满意度　出处：《实用妇产科杂志》2015年03期 　论文类型：期刊论文

【摘要】：目的:初步调查依托孕烯皮下埋植剂依伴侬(Implanon)的使用现状,为临床进一步推广使用提供依据。方法:对2013年3月1日至2014年4月2日到华西第二医院妇产科门诊进行Implanon皮下埋植的使用者64例进行随访调查。结果:Implanon避孕有效率100.00%,痛经缓解率91.67%,提前终止率6.67%。其主要不良反应有:月经改变78.33%,激素避孕相关不良反应58.33%,体重增加26.67%等。认知度调查:知道Implanon 3种及以上优点的使用者只占11.67%,知道Implanon除月经改变外的3种及以上不良反应的使用者只占16.67%。使用者总满意率41.67%,其中A组(避孕组)满意率25.71%,续用率48.57%;B组(治疗组)满意率64.00%,续用率72.00%。认知度和满意度呈正相关关系(rs=1,P0.0001)。结论:Implanon是一种高效且安全的皮下埋植避孕剂,能明显缓解痛经、减少经量。Implanon的最主要不良反应为月经改变,发生率高,医师在皮下埋植前和皮下埋植中应向患者详细解释可能出现的不良反应,正确对症处理,避免患者因认知不足而引起的焦虑及满意度下降。
[Abstract]:Objective: to investigate the current situation of the use of Implanon, a subcutaneous implant based on pregnancy. To provide the basis for further promotion of clinical use. Methods:. From March 1st 2013 to April 2nd 2014, 64 patients who underwent Implanon subcutaneous implantation in outpatient department of gynecology and obstetrics of West China second Hospital were followed up. Results:. The effective rate of Implanon contraception was 100.00%. The remission rate of dysmenorrhea was 91.67 and the early termination rate was 6.67.The main adverse reactions were: menstrual change 78.33 and hormonal contraceptive related adverse reactions 58.33%. Weight gain 26.67% et al. Cognitive survey: only 11.67% users knew three or more of the advantages of Implanon. Only 16. 67 users knew that there were 3 or more adverse reactions in Implanon except menstrual change. The total satisfaction rate of users was 41.67%. The satisfaction rate of group A (contraceptive group) was 25.71 and the rate of continuous use was 48.57; The satisfaction rate of group B (treatment group) was 64.00 and the rate of continuous use was 72.00. There was a positive correlation between cognition and satisfaction. P 0.0001.ConclusionImplanon is an effective and safe contraceptive for subcutaneous implantation, which can relieve dysmenorrhea obviously. The main adverse reaction of reducing menstrual volume. Implanon is menstrual change, the incidence is high. Doctors should explain the possible adverse reactions to patients before and after subcutaneous implantation. Correct treatment to avoid anxiety and satisfaction due to cognitive deficiency.
【作者单位】：四川大学华西第二医院;
【分类号】：R169.41
【正文快照】： 皮下埋植避孕药物应用于临床已有四十多年,传统的皮下埋植需埋植6根或2根硅胶棒,其植入和取出均较为不便,且容易游走。2006年经美国FDA批准上市的依托孕烯皮下埋植剂依伴侬(Implanon)为单根乙烯-醋酸乙烯酯(ethylenevinglacetate,EVA)植入剂,所含药物为第三代孕激素依托孕烯(e

【相似文献】